• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

CMS sets reimbursement rates for prostate, renal cryoablation

Article

The Centers for Medicare & Medicaid Services has increased hospital outpatient and ambulatory surgical center reimbursement rates for cryoablation treatments for prostate cancer, and has created a reimbursement code and rate for percutaneous renal cryoablation. The new rates will go into effect in 2008.

The Centers for Medicare & Medicaid Services has increased hospital outpatient and ambulatory surgical center reimbursement rates for cryoablation treatments for prostate cancer, and has created a reimbursement code and rate for percutaneous renal cryoablation. The new rates will go into effect in 2008.

Under the new rates, reimbursement for prostate cryoablation performed in an outpatient hospital setting (APC code 674) for patients who do not stay overnight was raised from $6,685.05 to $7,816.10, a 16.9% increase. For procedures performed at ambulatory surgical centers (ASC code 55873), the reimbursement rate was raised from $1,339.00 to $6,219.63, an increase of 364%.

CMS also has accepted the recommendation from AMA’s Specialty Society Relative Value Update Committee and has created a specific clinical reimbursement code and rate for percutaneous renal cryoablation. The new code (CPT 50593) will be paid as an adjusted average in the $440 range.

Related Videos
Mature woman with her doctor | Image Credit: © pucko_ns - stock.adobe.com
Gary D. Steinberg, MD, an expert on bladder cancer
Jaleh Fallah, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.